
News|Articles|August 2, 2010
Formulary Digital Edition, August 2010
Disease-modifying therapy in adult relapsing-remitting multiple sclerosis; Focus on fingolimod; Agents in late-stage development for the management of weight
Advertisement
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Managed Healthcare Executive
1
Cobenfy in Practice: Hope, Hurdles, and the Next Chapter in Schizophrenia Care
2
FDA Approves Gazyva for Lupus Nephritis in Adults
3
Data Presented Shows AREDS Vitamins Don’t Slow Geographic Atrophy in AMD | AAO 2025
4
Jury Still Out on Effect of GLP-1 Drugs on the Eyes | AAO 2025
5